During the past decade, General hospital Celje conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General hospital Celje" #1 sponsor was "Celgene" with 3 trials, followed by "Abivax S.A." with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "General and Teaching Hospital Celje" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General hospital Celje" #1 collaborator was "University of Ljubljana" with 2 trials as a collaborator, "Vizera d.o.o." with 2 trials as a collaborator, "General Hospital Izola" with 1 trials as a collaborator, "General Hospital Murska Sobota" with 1 trials as a collaborator and "General and Teaching Hospital Celje" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "General hospital Celje" are "Crohn Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Diabetic Foot Ulcer" (2 trials), "Ulcerative Colitis" (2 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "General hospital Celje" in a lesser frequency.

Most popular intervention types in "General hospital Celje" are "Drug" (12 trials), "Other" (4 trials), "Device" (3 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ozanimod" (3 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

The vast majority of trials in "General hospital Celje" are 19 trials for "All" genders.

Currently, there are NaN active trials in "General hospital Celje". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in General hospital Celje, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in General hospital Celje, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".